CD19-directed CAR-T Cell Therapy Manufactured Using a Next-Generation Process, for Severe, Refractory Autoimmune Diseases

Time: 10:30 am
day: Day Two Track B, AM

Details:

• Optimized autologous CAR-T construct

• Translational data for B-cell depletion and immune reset in autoimmune patients

Speakers: